Car-T Central
  • CAR-T Fundamentals
  • CAR-T in Australia
  • Clinical Management
  • Expert Opinion
  • About Us
  • Register
Car-T Central
  • CAR-T Fundamentals
  • CAR-T in Australia
  • Clinical Management
  • Expert Opinion
  • About Us
  • Register

tisagenlecleucel

All EHA CAR-T Abstracts

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Comparison of four flow cytometry methods for CART-19 detection in B cell precursor acute lymphoblastic leukemia paediatric patients

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Granulocyte colony stimulating factor (GCSF) administration does not affect prevalence and severity of CRS, ICANS nor outcome in patients with R/R large B cells lymphomas treated by CD19 CAR-T

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Multi-technique follow-up of lymphoma patients undergoing commercial CAR-T cell therapy: experience from a single centre

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

TMTV correlates with early progression (EP) after CD19 CAR T-cell therapy in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

BIANCA phase 2, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult patients with relapsed/refractory B-cell non-hodgkin lymphoma

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

An assessment of the reimbursement landscape to CAR T-cell therapy in Europe

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Tisagenlecleucel for pediatric/young adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia: preliminary report of b2001x focusing on prior exposure to blinatumomab and inotuzumab

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Diclofenac in the management of cytokine release syndrome after CAR-T infusion in B-ALL pediatric patients

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Refractory hemophagocytic lymphohistiocytosis/macrophage-activation syndrome (hlh/mas) following treatment with tisagenlecleucel for refractory B-cell lymphoma

Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]

Posts navigation

Previous
Privacy Policy © Copyright Bastion Brands 2022